• 1
    Drucker, DJ. (2002) Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122: 531544.
  • 2
    Stanley, S., Wynne, K., Bloom, S. (2004) Gastrointestinal satiety signals III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. Am J Physiol Gastrointest Liver Physiol. 286: G693G697.
  • 3
    Brubaker, P. L., Anini, Y. (2003) Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2. Can J Physiol Pharmacol. 81: 10051012.
  • 4
    Onaga, T., Zabielski, R., Kato, S. (2002) Multiple regulation of peptide YY secretion in the digestive tract. Peptides 23: 279290.
  • 5
    Sjolund, K., Sanden, G., Hakanson, R., Sundler, F. (1983) Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 85: 11201130.
  • 6
    Englyst, H. N., Kingman, S. M., Cummings, JH. (1992) Classification and measurement of nutritionally important starch fractions. Eur J Clin Nutr. 46: (Suppl 2), S33S50.
  • 7
    Wang, X., Brown, I. L., Khaled, D., Mahoney, M. C., Evans, A. J., Conway, PL. (2002) Manipulation of colonic bacteria and volatile fatty acid production by dietary high amylose maize (amylomaize) starch granules. J Appl Microbiol. 93: 390397.
  • 8
    Zhou, J., Roane, D. S., Xi, X., et al (2003) Short-term food restriction and refeeding alter expression of genes likely involved in brain glucosensing. Exp Biol Med (Maywood) 228: 943950.
  • 9
    Adrian, T. E., Ferri, G. L., Bacarese-Hamilton, A. J., Fuessl, H. S., Polak, J. M., Bloom, SR. (1985) Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89: 10701077.
  • 10
    Lundberg, J. M., Tatemoto, K., Terenius, L., et al (1982) Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA 79: 44714475.
  • 11
    Onaga, T., Yoshida, M., Inoue, H., Yokota, H. (2000) Regional distribution and plasma concentration of peptide YY in sheep. Peptides 21: 655667.
  • 12
    Badman, M. K., Flier, JS. (2005) The gut and energy balance: visceral allies in the obesity wars. Science 307: 19091914.
  • 13
    Dumoulin, V., Moro, F., Barcelo, A., Dakka, T., Cuber, JC. (1998) Peptide YY, glucagon-like peptide-1, and neurotensin responses to luminal factors in the isolated vascularly perfused rat ileum. Endocrinology 139: 37803786.
  • 14
    Batterham, R. L., Cohen, M. A., Ellis, S. M., et al (2003) Inhibition of food intake in obese subjects by peptide YY3–36. N Engl J Med. 349: 941948.
  • 15
    Moran, T. H., Smedh, U., Kinzig, K. P., Scott, K. A., Knipp, S., Ladenheim, EE. (2005) Peptide YY(3–36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol. 288: R384R388.
  • 16
    Batterham, R. L., Cowley, M. A., Small, C. J., et al (2002) Gut hormone PYY(3–36) physiologically inhibits food intake. Nature 418: 650654.
  • 17
    Chelikani, P. K., Haver, A. C., Reidelberger, RD. (2005) Intravenous Infusion of Peptide YY(3–36) Potently Inhibits Food Intake in Rats. Endocrinology 146: 879888.
  • 18
    de Fonseca, F. Rodriquez, Navarro, M., Alvarez, E., et al (2000) Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats. Metabolism 49: 709717.
  • 19
    Strader, A. D., Woods, SC. (2005) Gastrointestinal hormones and food intake. Gastroenterology 128: 175191.
  • 20
    Higgins, JA. (2004) Resistant starch: metabolic effects and potential health benefits. J AOAC Int. 87: 761768.
  • 21
    Kendall, C. W., Emam, A., Augustin, L. S., Jenkins, DJ. (2004) Resistant starches and health. J AOAC Int. 87: 769774.
  • 22
    Andrieux, C., Pacheco, E. D., Bouchet, B., Gallant, D., Szylit, O. (1992) Contribution of the digestive tract microflora to amylomaize starch degradation in the rat. Br J Nutr. 67: 489499.
  • 23
    Jenkins, D. J., Vuksan, V., Kendall, C. W., et al (1998) Physiological effects of resistant starches on fecal bulk, short chain fatty acids, blood lipids and glycemic index. J Am Coll Nutr. 17: 609616.
  • 24
    Cuff, M. A., Shirazi-Beechey, SP. (2004) The importance of butyrate transport to the regulation of gene expression in the colonic epithelium. Biochem Soc Trans. 32: 11001102.
  • 25
    Halestrap, A. P., Price, NT. (1999) The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem J. 343: 281299.
  • 26
    Fu-Cheng, X., Anini, Y., Chariot, J., Voisin, T., Galmiche, J. P., Roze, C. (1995) Peptide YY release after intraduodenal, intraileal, and intracolonic administration of nutrients in rats. Pflugers Arch. 431: 6675.
  • 27
    Cuche, G., Cuber, J. C., Malbert, CH. (2000) Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway. Am J Physiol Gastrointest Liver Physiol. 279: G925G930.
  • 28
    Plaisancie, P., Dumoulin, V., Chayvialle, J. A., Cuber, JC. (1996) Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon. J Endocrinol. 151: 421429.
  • 29
    Lee, K., Li, B., Xi, X., Suh, Y., Martin, RJ. (2005) Role of neuronal energy status in the regulation of adenosine 5′-monophosphate-activated protein kinase, orexigenic neuropeptides expression, and feeding behavior. Endocrinology 146: 310.